key: cord-0992462-6koqdc9e authors: Krishna, Usha R. title: Reproductive Health During the COVID-19 Pandemic date: 2021-08-30 journal: J Obstet Gynaecol India DOI: 10.1007/s13224-021-01546-2 sha: 2c006d3f1436be975eace2979751ef4472b5370b doc_id: 992462 cord_uid: 6koqdc9e Globally reproductive health services such as contraception and abortion are impacted and are not accessible to a considerable population. The International Planned Parenthood Federation reported anticipated shortage of contraception as the lockdown measures led to reduction in the manufacturing of contraceptives. A recent analysis by the Guttmacher Institute estimated the potential effects of the pandemic. It was found that a 10% decline of sexual and reproductive health services due to COVID-19, would mean an additional 15.4 million unintended pregnancies, over 3.3 million unsafe abortions and 28,000 maternal deaths. The UN Secretary General has issued a call to continue the delivery of sexual and reproductive health services even without prescription. The focus is now to provide vaccines, and therefore, a number of research organizations and pharmaceutical industries are working on their production. One of the reasons for vaccine refusal is the concern that it may affect female and male reproductive functions. However, it is important to correct this misunderstanding as vaccination does not affect fertility. In most cases, vaccination during pregnancy and lactation can be considered safe and effective. The Indian population is about 1.4 billion and it is estimated that 1 out of 6 people on this planet belong to India [1] . Therefore, population stabilization remains the biggest priority during the COVID-19 pandemic. This pandemic already had a significant impact on our health system and it is important to continue delivering reproductive health, with contraception and safe abortion. The current global situation as of June 2021 indicates that over 177 million people have been infected with COVID-19, with the highest number of cases in USA, India, Brazil, Russian Federation and Columbia [2] . There have been more than a million deaths. Globally reproductive health services such as contraception and abortion are impacted and are not accessible to a considerable population. The International Planned Parenthood Federation reported anticipated shortage of contraception as the lockdown measures led to reduction in the manufacturing of contraceptives [3] . UNFPA noted that about 47 million couples in 114 low and middleincome countries will not have access to contraception and this would result in over 7 million unintended pregnancies. In Family Planning Association of India, 40 centers made every effort to continue the services through the dedication of doctors and health workers. The following data is from April 2020 to September 2020. In Obstetric services were offered to 624,374, pediatric services to 655,837 children and 15,687 sub-fertility services were also available [4] . The services were certainly most exemplary with good leadership. Gwalior, Kalchini and Ahmedabad had more than 100,000 cases of COVID each. A recent analysis by the Guttmacher Institute estimated the potential effects of the pandemic [5] . It was found that a 10% decline of sexual and reproductive health (SRH) services due to COVID-19, would mean an additional 15.4 million unintended pregnancies, over 3.3 million unsafe abortions and 28,000 maternal deaths. In a study by Foundation of Reproductive Health Services India (FRHSI), an estimated 24.5 million couples would not be able to access contraceptives in 2020. Method wise the loss is estimated at 530,737 sterilizations, 709,088 IUCDs, 509,360 injectable contraceptives, 20 million cycles of OCPs, 827,332 ECPs and 342.1 million condoms [6] . This is likely to result in an additional 1.94 million unintended pregnancies, 555,833 live births, 1.18 million abortions (including 681,883 unsafe abortions) and 1,425 maternal deaths. Unsafe abortion is one of the main causes of maternal mortality worldwide, with at least 22,800 deaths and over 7 million hospitalized cases. During this period, management of health problems has been a difficult task due to several other problems arising due to the pandemic. Migrants walking to their villages, with joblessness, desperation, hunger and malnutrition were particularly vulnerable. The estimated migrants were 139 million in India. The problems of gender-based violence also seemed to have grown. This highly infectious airborne disease is difficult to treat, especially in places like Dharavi, Asia's largest slum. Symptomatic and even asymptomatic patients can test postive for COVID infection. Therefore, testing is most important. There is tremendous variation in the data from various centers and various countries. Every month new information gets updated. RCTPCR is the gold standard test. Antigen antibody tests are cheaper but can have false positive results too [7] . COVID patients can have fever, body ache, cough, cold, respiratory infection, respiratory distress, inability to smell and taste and even mental health and behavioral problems. The new coronavirus ACE3 also affects the kidney and gastrointestinal tract. Besides, it can have a direct effect on the reproductive system (ACE2), which can lead to the impairment of male and female fertility [8] . Elderly patients with poor income with diabetes and hypertension, etc., are more prone to develop complications. Postpartum psychosis and anxiety are also seen. The UN Secretary General has issued a call to continue the delivery of sexual and reproductive health services even without prescription. COVID-19 has thrown the world economy into a recession, the likes of which hasn't been seen since the Great Depression (1929-33). Restrictions imposed on the movement of people to curb the spread of the virus, resulted in a huge reduction of employment and capital investment. In 2020, many economies (including the US economy) saw a reduction of over 30% in output. The guidelines for the general population are to stay at home, self-isolate, frequently wash hands, cover nose and mouth with a mask and keep a safe distance of at least six feet from each other. When out of home, refrain from crowds and poorly ventilated areas, use a medical or surgical mask and regularly clean and disinfect surfaces. Very special counseling and support is essential as COVID-19 has a devastating effect on women and girls. The recommendation is to prescribe or dispense multi-month refills of the pill to minimize trips to the pharmacy or clinic. Health insurance plans should waive time limitations [9] . The progesterone only pill can safely be started for individuals even without face-to-face consultation, and prescription can be given for 3-6 months. Injection DMPA or insertion of intrauterine contraception or subcutaneous implants are suitable options to LNG IUD and the copper IUD. Emergency contraception should be available without delay in appropriate cases and termination of pregnancy by medical and surgical methods should be available. These facilities supported with telemedicine and self-care should be promoted and explained to women and men. Delivering contraceptives to the doorstep is crucial. For postpartum contraception, counseling is done even before the delivery and is provided to women before discharge from the hospital. It reduces the need for further contact. Breastfeeding can continue. The use of postpartum IUCD insertion has great potential in this pandemic situation. Institutionalization of immediate postpartum IUCD has been studied in India at 6 hospitals over 3 years [10] . The impact of using nurses to perform postpartum intrauterine device insertions has been excellent. In a FIGO postpartum IUD initiative 2013-2020, it has been reported that a total of 253,629 women were counseled in the antenatal period. Of these 131,425 (52%) delivered at the institution, 28,695 (22%) had a PPIUD insertion, with post-placental insertion in 61% and insertion after cesarean section in 39% [11] . Routine elective services have been delayed by both government and private setups but they need to be revived as the pandemic can last longer. During the pandemic, the health of staff has to be monitored and back-up staff should be provided. The provision of contraceptives short term and long acting along with counseling and access to services should be available. It is important to maintain the safety and wellbeing of staff, health workers and program beneficiaries. Besides this, the staff needs assistance for documentation. Prevention and control of infection is essential with vaccination and PPE (personal protective equipment). It is vital to ensure that the health workers have enough family planning supplies and are able to provide counseling and continue training. As the COVID-19 pandemic is a global health emergency, it has caused major disruption in health care services. The pandemic affected mental health and social interaction in a negative manner, which is a major concern. Even after the peak, continuation of sexual reproductive health and contraception are very essential. Permanent contraception like sterilization can be done after cesarean and even after vaginal delivery in appropriate cases where expertise is available. Counselling should be provided about the use of lactational amenorrhea and injection DMPA which can be continued even after 3 months if desired. UNFPA highlighted 3 things to know during the pandemic. The focus is now to provide vaccines, and therefore, a number of research organizations and pharmaceutical industries are working on production. The traditional vaccine has a protective effect against pathogens. DNA vaccine works by introducing a genetic sequence of a viral antigen in the host cells. When most people in a community are vaccinated, the ability of pathogens to spread is limited. After preclinical trials, there are phase 2 and 3, and later post marketing trials. The aim of WHO is to enroll participants from 470 sites in 34 countries for vaccination. Some vaccines need 2 doses. Serum Institute of India has collaborated with Oxford. • One of the reasons for vaccine refusal is the concern that it may affect female and male reproductive functions. However, it is important to correct this misunderstanding as vaccination does not affect fertility [13] . There has also been considerable controversy regarding vaccination during pregnancy and lactation. In most cases, vaccination during pregnancy and lactation can be considered safe and effective [14] . COVID-19 causes significant morbidity and mortality, with respiratory illness requiring hospitalization in 5% to 6% of all SARS- Vaccines can save millions as they work by training and preparing the body's natural defenses-the immune system. Vaccine development and approval usually take several years and need strong collaborations with government and academia researchers, health care professionals and peer companies. Scientists around the world identify and share genetic sequences of the new coronavirus to accelerate the vaccine research. The technology is to produce stronger immune responses and design multiple candidates for evaluation. Researchers also looked at multiple ways to shorten time such as combining stages, testing more than one version of the vaccine and sending batches of data to government regulators. According to the WHO, there are more than 50 vaccine candidates around the world in clinical trials. The makers of three vaccines that are closest to global distribution are Pfizer, Moderna and AstraZeneca [15] . Messenger RNA vaccines are some of the first COVID-19 vaccines that have been recently approved in regulatory agencies. It can protect against infection and teach our cells how to make protein or portion of protein that triggers an effective immune response within the human body. This prevents us from getting infected. COVID-19 vaccines are under trial in India. Pfizer USA BioNTech Germany BNT162b2. • mRNA vaccine-part of the coronavirus genetic code is injected into the body, triggering the body to begin making viral proteins, but not the whole virus, which is enough to train the immune system to attack. • 95% effective in clinical trials. • arrives at a temperature between − 80 °C and − 60 °C in a container with dry ice (should be stored in an ultra-cold freezer at this temperature). • Needs 2 shots, 21 days apart. • Johnson & Johnson has a one dose vaccine and is 76% effective overall. The vaccine is 85% effective in preventing severe COVID-19 complications requiring hospitalization. The National Institute for Research in Reproductive Health (NIRRH of ICMR) in recent weeks has shown that COVID positive mothers can have vertical transmission through the placental barrier. In the 1st trimester, transmission through the syncytial trophoblast cells can occur. In the 2nd trimester, extra villus trophoblasts and endovascular trophoblasts are responsible. Research is still ongoing with a registry of 3000 pregnant patients and follow-up of neonates. Family planning advice should be integrated into COVID-19 messages using channels like social media, TV and radio. Telemedicine should be provided through online screening, education and counseling. The COVID-19 pandemic may last even after its peak, and therefore, contraception and safe abortion should be considered essential and their availability and access ensured and continued. To conclude, health care facilities should continue to provide family planning and abortion services as essential health services, with telemedicine being a useful counseling method [16] . Office of the Registrar General & Census Commissioner, India Ministry of Home Affairs, Government of India THE Family planning 2020 PROGRESS REPORT The website of FPAI, work in Covid 19 International perspectives on sexual and reproductive health Impact of COVID 19 on India's Family Planning Program Policy Brief Effect of COVID-19 on the Special Issue: Institutionalization of postpartum intrauterine devices Impact of COVID-19 on Family Planning: What we know one year into the pandemic. UNFPA TECHNICAL NOTE Information as of 11 Episode #41 -Vaccines, pregnancy, menstruation, lactation and fertility COVID-19 Vaccination Considerations for Obstetric-Gynecologic Care. Practice Advisory COVID-19 vaccinations: What's the progress? Mechanisms for mother-to-child transmission of COVID-19. HEALTH & MEDICINE and COVID-19. India Bioscience Posted on Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations Conflict of interest There is no conflict of interest. Usha R. Krishna is renowned in the field of Obstetrics and Gynecology with vast experience in Fertility Control, Safe Abortions, Perinatology and Community Health. She is deeply involved and interested in medical social work such as setting up a nursing college in Hegdewar hospital (Aurangabad), skill development for adolescents in "Jagruti" a Research Centre in KEM Hospital Pune. She has contributed to study of Non Communicable diseases conducted by Family Planning Association Mumbai branch and skill development of tribal children at Kalinga Institute of Social Science (KISS) in Bhuvaneshwar.